Related Experiment Video
Updated: Jan 22, 2026

Studying Membrane Biogenesis with a Luciferase-Based Reporter Gene Assay
Published on: September 7, 2008
Luciferase-based reporting of suicide gene activity in murine mesenchymal stem cells
Dario Gerace1, Rosetta Martiniello-Wilks1,2, Rosaline Habib1
1The School of Life Sciences and the Centre for Health Technologies, University of Technology Sydney, Sydney, Australia.
Abstract:
Due to their ease of isolation, gene modification and tumor-homing properties, mesenchymal stem cells (MSCs) are an attractive cellular vehicle for the delivery of toxic suicide genes to a variety of cancers in pre-clinical models. In addition, the incorporation of suicide genes in stem cell-derived cell replacement therapies improves their safety profile by permitting graft destruction in the event of unexpected tumorigeneses or unwanted differentiation. Due to the functional requirement of ATP for the Firefly luciferase gene Luc2 to produce light, luciferase-based reporting of cytotoxicity can be engineered into potential cell therapies. Consequently, we nucleofected mammalian expression plasmids containing both the Luc2 and the yeast fusion cytosine deaminase uracil phosphoribosyltransferase (CDUPRT) genes for expression in murine MSCs to assess luciferase as a reporter of suicide gene cytotoxicity, and MSC as vehicles of suicide gene therapy. In vitro bioluminescence imaging (BLI) showed that following the addition of the non-toxic prodrug fluorocytosine (5-FC), CDUPRT-expressing MSCs displayed enhanced cytotoxicity in comparison to Luc2 reporter MSC controls. This study demonstrates the utility of luciferase as a reporter of CDUPRT-mediated cytotoxicity in murine MSC using BLI.
Insights
Mesenchymal stem cells (MSCs) carrying a suicide gene demonstrated effective cancer cell killing when treated with a prodrug. Luciferase imaging accurately reported this gene therapy
Area of Science:
- Oncology
- Stem Cell Biology
- Gene Therapy
Background:
- Mesenchymal stem cells (MSCs) are promising for cancer gene therapy due to their tumor-homing ability.
- Suicide gene therapy in stem cell therapies enhances safety by allowing graft elimination.
- Luciferase reporters can monitor cytotoxicity in cell therapies.
Purpose of the Study:
- To evaluate mesenchymal stem cells (MSCs) as vehicles for suicide gene therapy.
- To assess the utility of luciferase as a reporter for suicide gene-mediated cytotoxicity.
- To validate the use of in vitro bioluminescence imaging (BLI) for monitoring therapeutic outcomes.
Main Methods:
- Murine MSCs were engineered to express both the Luc2 luciferase gene and the yeast cytosine deaminase uracil phosphoribosyltransferase (CDUPRT) suicide gene.
- In vitro studies involved treating engineered MSCs with the prodrug 5-fluorocytosine (5-FC).
- Bioluminescence imaging (BLI) was used to monitor cytotoxicity in real-time.
Main Results:
- CDUPRT-expressing MSCs showed significantly enhanced cytotoxicity upon 5-FC treatment compared to control MSCs expressing only Luc2.
- BLI successfully visualized and quantified the prodrug-induced cell death.
- The study confirmed MSCs' potential as effective delivery vehicles for suicide gene therapy.
Conclusions:
- Luciferase serves as a reliable reporter for CDUPRT-mediated cytotoxicity in MSCs.
- This approach validates the use of BLI for monitoring suicide gene therapy efficacy.
- Engineered MSCs hold promise for targeted cancer treatment strategies.
Related Concept Videos
Mesenchymal Stem Cells
Reporter Genes
Induced Pluripotent Stem Cells
Adult Stem Cells
Embryonic Stem Cells
Cell Specific Gene Expression

